专利名称：USE OF CDK9 INHIBITORS TO REDUCE
CARTILAGE DEGRADATION
发明人：Dominik HAUDENSCHILD,Paul Di
CESARE,Jasper YIK,Blaine CHRISTIANSEN
申请号：US15356231申请日：20161118
公开号：US20170246156A1公开日：20170831
摘要：The present invention relates to the use of cyclin-dependent kinase 9 (CDK9)inhibitors to reduce, inhibit and/or prevent cartilage degradation. CDK9 inhibitors can beused to reduce, inhibit and/or prevent cartilage degradation and loss of cartilage viabilityduring allograft storage. CDK9 inhibitors can be used as a post-injury interventiontreatment to reduce, inhibit and/or prevent the acute cellular responses that lead tofuture cartilage degradation and osteoarthritis.
申请人：The Regents of the University of California
地址：Oakland CA US
国籍：US
更多信息请下载全文后查看
因篇幅问题不能全部显示，请点此查看更多更全内容